Anil Manghnani of Modern Shares & Stock Brokers is of the view that one can buy Cipla between Rs 205-213 for a target of Rs 225-249.

Manghnani told CNBC-TV18, "The initial burst, which has reflected in pharma sector indices having shown a major breakout after three-four year downtrend it is probably over and that is because of the way Ranbaxy and Glenmark has sort of moved. But I think just with the breakout sort of scenario now you just go out and buy every fall. I think Cipla has not really moved as much compared to Ranbaxy, Sun Pharma, Glenmark so that is probably one you can look at buying right now. So Rs 213 to Rs 205 you start buying with a target closer to Rs 225-249 sorts of levels."

Disclosure: It is safe to assume that analyst and his clients may have an interest in the above stocks/sectors.